Slide background

Gtree Pharmaceuticals Co., Ltd.
Gtree Pharmaceuticals Co., Ltd. was established in June 2014 for development of biopharmaceutical products, and is currently in development of GBT-201 (treatment for ophthalmic diseases) and GBT-101 (treatment for dermal diseases) with plans to conduct clinical trials in Korea and the United States.

Gtree Pharmaceutical’s research and development

ophthalmic disease

Rare disease

программа для взлома Одноклассников – OdnoMonsterможно ли детектор лжи обманутьдоска фанераcargo annual conferenceмакияж с золотом